Endocannabinoid signalling in the blood of patients with schizophrenia
<p>Abstract</p> <p>Aim</p> <p>To test the hypothesis that schizophrenia might be associated with alterations of the endogenous cannabinoid system in human blood.</p> <p>Results</p> <p>Blood from 20 healthy volunteers and 12 patients with schizoph...
Main Authors: | Orlando Pierangelo, De Petrocellis Luciano, De Marchi Nicola, Daniele Fabiana, Fezza Filomena, Di Marzo Vincenzo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-08-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.Lipidworld.com/content/2/1/5 |
Similar Items
-
Endocannabinoids and Schizophrenia
by: Stéphane Potvin, et al.
Published: (2010-10-01) -
Endocannabinoids, Related Compounds and Their Metabolic Routes
by: Filomena Fezza, et al.
Published: (2014-10-01) -
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
by: John M McPartland, et al.
Published: (2014-01-01) -
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
by: Lea Tunisi, et al.
Published: (2021-02-01) -
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
by: Ana Cabranes, et al.
Published: (2005-11-01)